Evaluate the Efficacy and Safety of "Formosa 1-Breath Free (NRICM101) " in Subjects With the Symptoms of COVID-19 or Influenza-like Disease

NCT06175468 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

170

Enrollment

OTHER

Sponsor class

Conditions

Influenza Viral Infections
COVID-19

Interventions

DRUG: Formosa 1-Breath Free (NRICM101)
DRUG: Placebo control drug

Sponsor

China Medical University Hospital

Collaborators

[object Object]
[object Object]
[object Object]